594
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis

ORCID Icon, , , , ORCID Icon, , ORCID Icon, & show all
Pages 1210-1219 | Received 25 Jun 2021, Accepted 14 Jul 2021, Published online: 01 Aug 2021

References

  • Fried LP, Tangen CM, Walston J, Cardiovascular Health Study Collaborative Research Group, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–156.
  • Tandon P, Montano-Loza AJ, Lai JC, et al. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol. 2021;75 (Suppl 1):S147–S162.
  • Tapper EB, Konerman M, Murphy S, et al. Hepatic encephalopathy impacts the predictive value of the fried frailty index. Am J Transplant. 2018;18(10):2566–2570.
  • Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatol. 2017;66(2):564–574.
  • Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther. 2020;51(1):64–77.
  • Laube R, Wang H, Park L, et al. Frailty in advanced liver disease. Liver Int. 2018;38(12):2117–2128.
  • Dunn MA, Josbeno DA, Tevar AD, et al. Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization. Am J Gastroenterol. 2016;111(12):1768–1775.
  • Lai JC, Covinsky KE, McCulloch CE, et al. The liver frailty index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis. Am J Gastroenterol. 2018;113(2):235–242.
  • Lai JC, Dodge JL, McCulloch CE, et al. Frailty and the burden of concurrent and incident disability in patients with cirrhosis: a prospective cohort study. Hepatol Commun. 2020;4(1):126–133.
  • Tapper EB, Finkelstein D, Mittleman MA, et al. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatol. 2015;62(2):584–590.
  • Cron DC, Friedman JF, Winder GS, et al. Depression and frailty in patients with end-stage liver disease referred for transplant evaluation. Am J Transplant. 2016;16(6):1805–1811.
  • Tandon P, Tangri N, Thomas L, et al. A rapid bedside screen to predict unplanned hospitalization and death in outpatients with cirrhosis: a prospective evaluation of the clinical frailty scale. Am J Gastroenterol. 2016;111(12):1759–1767.
  • Lai JC, Segev DL, McCulloch CE, et al. Physical frailty after liver transplantation. Am J Transplant. 2018;18(8):1986–1994.
  • Lai JC, Rahimi RS, Verna EC, et al. Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study. Gastroenterology. 2019;156(6):1675–1682.
  • Leurmarnkul W, Meetam P. Properties testing of the retranslated SF-36 (Thai version). Thai J Pharm Sci. 2005;29:69–88.
  • EASL Clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–460.
  • de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752.
  • Roman E, Parramon M, Flavia M, et al. Frailty in outpatients with cirrhosis: a prospective observational study. Liver Int. 2021;41:357–368.
  • Sinclair M, Poltavskiy E, Dodge JL, et al. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist. WJG. 2017;23(5):899–905.
  • Orr JG, Homer T, Ternent L, et al. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61(5):1158–1165.
  • Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–178.
  • Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7(7):793–799.
  • Kok B, Whitlock R, Ferguson T, et al. Health-related quality of life: a rapid predictor of hospitalization in patients with cirrhosis. Am J Gastroenterol. 2020;115(4):575–583.
  • Tapper EB, Kanwal F, Asrani SK, et al. Patient-reported outcomes in cirrhosis: a scoping review of the literature. Hepatol. 2018;67(6):2375–2383.
  • Tapper EB, Baki J, Parikh ND, et al. Frailty, psychoactive medications, and cognitive dysfunction are associated with poor patient-reported outcomes in cirrhosis. Hepatol. 2019;69(4):1676–1685.
  • Wang CW, Lebsack A, Chau S, et al. The range and reproducibility of the liver frailty index. Liver Transpl. 2019;25(6):841–847.
  • Desai AP, Mohan P, Nokes B, et al. Increasing economic burden in hospitalized patients with cirrhosis: analysis of a national database. Clin Transl Gastroenterol. 2019;10(7):e00062.
  • Asrani SK, Kamath PS. Natural history of cirrhosis. Curr Gastroenterol Rep. 2013;15(2):308.
  • Lai JC, Dodge JL, Kappus MR, Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study, et al. Changes in frailty are associated with waitlist mortality in patients with cirrhosis. J Hepatol. 2020;73(3):575–581.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.